The Lack of EpiPen Competitors is the FDA's Fault | Mises Wire https://mises.org/blog/lack-epipen-competitors-fdas-fault …
0 replies
1 retweet
2 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.